The first evidence of the connection between ferroptosis and antitumor immunity has been provided by Wang et al. These authors show that immunotherapy-activated CD8+ T lymphocytes induce ferroptosis in cancer cells through the downregulation of SLC7A11 and SLC3A2 genes encoding for the two subunits of system Xc-. The gene discussed is SLC3A2; the disease is cancer.